canyon landscape

ADvance II Study: DBS-f in Patients with Mild Alzheimer’s Disease

The primary efficacy objective of this study is to test the hypothesis that DBS-f stimulation (ON) will slow cognitive and functional progression of AD, as compared to no stimulation (OFF), by measuring baseline (pre-implantation) to 12-month change in the integrated Alzheimer’s disease rating scale (iADRS).
Open and enrolling subjects.
Phoenix, Arizona
Age Range
  • 65+
Total Participants
Primary Sponsor
Functional Neuromodulation Ltd